13F-HR filed by Woodline Partners LP
Woodline Partners LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 1,010 holding rows worth $25,809,366,483.
- Accession
- 0001172661-26-000861
- Filer
- CIK 1784547
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 1,010 entries on the cover page, a total value of $25,809,366,483 stated on the cover page (in dollars after the unit check, H1), rows summing to $25,809,366,483 with VALUE read as dollars as filed, 13F file number 028-20047. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DARDEN RESTAURANTS INC COM | 237194105 | Stock | 1,130 | $207,943 | dollars as filed | |
| LYONDELLBASELL INDUSTRIES NV SHS - A - | N53745100 | Stock | 4,707 | $203,813 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 145,971 | $166,407 | dollars as filed | |
| SNAP INC | 83304A106 | CL A | 19,842 | $160,125 | dollars as filed | |
| ENDAVA PLC ADS | 29260V105 | ADR | 24,522 | $154,979 | dollars as filed | |
| CNH INDL N V SHS | N20944109 | Stock | 16,134 | $148,755 | dollars as filed | |
| KALA BIO INC | 483119202 | COM NEW | 224,174 | $124,618 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 21,523 | $116,224 | dollars as filed | |
| CASI PHARMACEUTICALS INC COM NEW | G1933S101 | Stock | 133,406 | $113,395 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 14,957 | $26,773 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-000861 | this filing | 2026-02-17 | acceptance time not in the bulk data set |